Latest KFF Health News Stories
In a first-of-its-kind ruling, the Alabama Supreme Court has determined that embryos created for in vitro fertilization procedures are legally people. The decision has touched off massive confusion about potential ramifications, and the University of Alabama-Birmingham has paused its IVF program. Meanwhile, former President Donald Trump is reportedly planning to endorse a national 16-week abortion ban, while his former administration officials are planning further reproductive health restrictions for a possible second term. Lauren Weber of The Washington Post, Rachana Pradhan of KFF Health News, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
Lawsuits allege that several children under 18 in South Carolina have undergone examinations of their private parts during child abuse investigations — even when there were no allegations of sexual abuse. There’s a growing consensus in medicine that genital exams can be embarrassing, uncomfortable, and even traumatic.
Montana may join about a dozen other states in creating “safe havens” that keep health care professionals from facing scrutiny from licensure boards for seeking mental health or addiction treatment.
More than a quarter century after an inmate helped start a hospice program in one of the nation’s most notorious prisons, he is trying to spread the idea.
A report based on millions of urine drug tests found the United States is facing a rise in the use of multiple drugs at once, which not only is often more deadly but complicates treatment efforts.
Even as Anthem Blue Cross and University of California Health announced a contract agreement this month, analysts say patients are increasingly at risk of being affected by such disputes.
The expansion of Catholic hospitals nationwide leaves patients at the mercy of the church’s religious directives, which are often at odds with accepted medical standards.
A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration’s Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
After a decade of work, a Kentucky program launched to diagnose lung cancer earlier is beginning to change the prognosis for residents by catching tumors when they’re more treatable.
Nearly 2 million Medi-Cal enrollees, mainly people who are aged, disabled, or in long-term care, can now accumulate savings and property without limitations and still qualify for the state’s health insurance program for low-income residents. They join an additional roughly 12 million enrollees who already had no asset limits.
KFF Health News’ Céline Gounder explains the “five-day rule” on covid safety, how guidelines and testing have evolved, and how best to protect yourself and others.
Drug overdose deaths in California state prisons rebounded to near record levels last year, a big setback for corrections officials who thought they were on the right track with medication-assisted treatment efforts. Prison officials and attorneys representing prisoners blame fentanyl.
KFF Health News shares the crème de la crème of reader-submitted health policy valentines. Two of our favorites melted our hearts and inspired original illustrations.
Medicare pays hospitals about double what it pays other providers for the same services. The hospital lobby is fighting hard to make sure a switch to “site-neutral payments” doesn’t become law.
Lawmakers and regulators are trying to understand how AI is changing health care and how it should be regulated. The industry fears overreach.
Doctors, patients, and hospitals have railed for years about the prior authorization processes that health insurers use to decide whether they’ll pay for patients’ drugs or medical procedures. The Biden administration announced a crackdown in January, but some state lawmakers are looking to go further.
Resorting to crowdfunding to pay medical bills has become so routine, in some cases health professionals recommend it.
Recently, thousands of older Americans have been dying weekly of covid. But most Americans aren’t wearing masks in public, a move that could prevent infections. Many at-risk seniors aren’t getting antiviral therapies, and older adults in nursing homes aren’t getting vaccines. Why?
For the first time, a jury has convicted a parent of a school shooter of charges related to the child’s crime, finding a mother in Michigan guilty of involuntary manslaughter and possibly opening a new legal avenue for gun control advocates. Meanwhile, as the Supreme Court prepares to hear a case challenging the FDA’s approval of the abortion drug mifepristone, a medical publisher has retracted some of the journal studies that lower-court judges relied on in their decisions. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachana Pradhan of KFF Health News join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.